Quantcast

bryantBROWN Healthcare Helps Promote Angel® Whole Blood Separation System for Platelet-Rich Plasma (PRP) Therapy

July 17, 2012

Cytomedix selects award-winning healthcare communications agency bryantBROWN to promote the Angel Whole Blood Separation System. Contact bryantBROWN at http://www.bryantbrown.com for more information.

Los Angeles, CA (PRWEB) July 17, 2012

Award-winning healthcare communications agency bryantBROWN Healthcare has created the promotional campaign for the Angel Whole Blood Separation System for Cytomedix. Angel is an advanced blood processing device and disposable products used for the separation of whole blood into red cells, platelet-poor plasma (PPP), and platelet-rich plasma (PRP) in surgical settings.

Recently, PRP has been appearing frequently in the news, with reports of Tiger Woods, Rafael Nadal, Kobe Bryant, Alex Rodriguez, Hines Ward, Takashi Saito, Troy Polamalu, and other athletes receiving PRP treatment for sports injuries.

In addition, PRP is being used in hair restoration, skin rejuvenation and related aesthetic procedures, and a wide range of other applications.

bryantBROWN delivers research, strategic and tactical planning, brand concepting, design, copywriting, web and digital programming, and additional services to support the marketing and advertising programs of Angel. The goal is to market Angel to healthcare professionals and patients.

Says Bob Brown, bryantBROWN partner, “We´re very excited to be working with Cytomedix to promote Angel. It´s truly an innovative product with a variety of distinct advantages.”

For more information about all the advantages of the Angel Whole Blood Separation System, please visit http://www.cytomedix.com or yourangel(at)cytomedix(dot)com.

For more information about all the benefits that advertising campaigns created by bryantBROWN Healthcare offer medical device manufacturers, pharmaceutical companies, biotechnology companies, hospitals, health information technology firms, and advocacy organizations, visit http://www.bryantbrown.com or call Bob Brown at (310) 406-2460, extension 101.

About Cytomedix, Inc.

Cytomedix, Inc. is an autologous regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies for wound and tissue repair. The Company markets the AutoloGel System, a device for the production of autologous platelet-rich plasma (“PRP”) gel for use on a variety of exuding wounds and the Angel® Whole Blood Separation System, a blood processing device and disposable products used for the separation of whole blood into red cells, platelet poor-plasma (“PPP”), and PRP in surgical settings. On February 8, 2012, Cytomedix closed the acquisition of Aldagen, a biopharmaceutical company developing regenerative cell therapies based on its proprietary ALDH bright cell (“ALDHbr”) technology, currently in a Phase 2 trial for the treatment of ischemic stroke. For additional information please visit http://www.cytomedix.com.

About bryantBROWN

bryantBROWN Healthcare is an award-winning medical advertising agency that plans and implements strategic-driven promotional and educational campaigns for healthcare brands. For more than a decade, bryantBROWN has developed healthcare communications targeting consumer and professional audiences in all media–web, broadcast, and print–“everywhere in healthcare.” bryantBROWN is online at http://www.bryantbrown.com.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebhealthcarecommunications/medicaladvertising/prweb9412852.htm


Source: prweb



comments powered by Disqus